Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,479 stories, page 449 of 692

Advanced search

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

FDA panel supports broadening access to peptides popular on the gray market

NPROriginal source

🇺🇰Jul 23Regulatorygov.ukTier 1 · Regulatory source

DHSC counter-fraud strategy: 2026 to 2029

How the Department of Health and Social Care plans to prevent fraud, bribery and corruption in its a...

UK Department of Health and Social CareOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene hit the lower limit for three consecutive trading days in the aftermath of the U.S...

매일경제Original source

🇺🇰Jul 23Regulatorygov.ukTier 1 · Regulatory source

Shiga toxin-producing Escherichia coli (STEC): annual totals

The number of infections of Shiga-toxin producing Escherichia coli (STEC) reported in England and Wa...

UK Health Security AgencyOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Join ASCA2026 in Malaysia

ISAAA.orgOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Strong sales of Vyvgart push results of biotech company Argenx

Belga ShareOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Burning Rock Biotech Limited Sponsored ADR $BNR Shares Sold by Crcm LP

MarketBeatOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A – SSE:600513

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 1 · Regulatory source

UK and Switzerland collaborate to shape the future of space-enabled pharmaceuticals

GOV.UK blogsOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

IO Biotech founder brings key lessons to new top job: “I can get through a crisis”

medwatch.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Interview: How Tragedy Changed the FDA

Undark MagazineOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

AI biotech startup Cheiron launches $8 million seed round

The Korea News PlusOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

ARTHEx Biotech Publishes First Demonstration of Improvement in a DM1-related Behavioral Alteration in a Preclinical Model of Myotonic Dystrophy Type 1 (DM1)

PR NewswireOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Jamjoom Pharma Updates On Non-Binding Term Sheet With Pharmaceutical Investment Company

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Phase 3 trial of Zydus' Desidustat begins with hope for sickle cell patients

Indian Pharma PostOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Cash flow from investing activities of Teh Seng Pharmaceutical Mfg Co Ltd – TPEX:7860

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

BMC HQ canteen sealed by FDA over food safety lapses; dead fly, plastic thread found in food

Moneycontrol.comOriginal source

🌍Jul 23Mediasaama.comTier 2 · Direct publisher

Why Reviewing Labs and Adverse Events in Isolation Is a Safety Risk

SaamaOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

World Melting Point Meter - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene Hits Daily Loss Limit for Third Straight Session After U.S. Phase 3 Failure

Seoul Economic DailyOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Sinopep-Allsino Bio Pharmaceutical Co., Ltd. Class A – SSE:688076

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Opinion | Trump’s generic drug tariffs will drive up pharmaceutical prices

The Washington PostOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Zydus Lifesciences Gets Green Light For Phase III Desidustat Trial In Sickle Cell Patients

SahiOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Sartorius Stedim Biotech continues positive development and expands profitable growth

marketscreener.comOriginal source

🇫🇷Jul 23Industryinnate-pharma.comTier 1 · Company source

Innate Pharma to participate in a bladder cancer panel at the BTIG Virtual Biotechnology Conference

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), a clinical-sta...

Innate Pharma (IR)Original source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Is A Single-Patient KB801 Outcome Quietly Reframing Krystal Biotech's Clinical Narrative (KRYS)?

simplywall.stOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Chinese Ambassador to Zimbabwe Zhou Ding Visits China-aided Zimbabwe National Pharmaceutical Warehouse

EIN NewsOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

breitbart.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

How venture capital can unlock biotech’s long-term value

BiotechDispatchOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Tonghua Dongbao Pharmaceutical Co., Ltd. Class A – SSE:600867

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

FDA Reviews Controversial Peptide Injections Backed by Wellness Influencers

streamlinefeed.co.keOriginal source

🇩🇰Jul 23Researchhealthsciences.ku.dkTier 2 · Direct publisher

DNA vacuum reveals local wildlife in Danish nature

University of Copenhagen - HealthOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A – SSE:600513

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Hangzhou Biotest Biotech Co., Ltd. Class A – SSE:688767

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Rise of AI and Biotech Reshaping Healthcare Sector

HKTDC ResearchOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Japan to mandate reporting on supplement-linked health issues

The Japan TimesOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Hangzhou Biotest Biotech Co., Ltd. Class A – SSE:688767

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Popular allergy medication recalled due to potentially life-threatening cross contamination

FOX WeatherOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

How New Marine UAS Orders And Space Biotech Bets At Redwire (RDW) Have Changed Its Investment Story

simplywall.stOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Honz Pharmaceutical Co., Ltd. Class A – SZSE:300086

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Hangzhou Biotest Biotech Co., Ltd. Class A – SSE:688767

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Bavaria emerges as global biotech hub with strong ecosystem

BioProcess InternationalOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

[Reporter’s Notebook] There Is No “Partial Success” in Clinical Trials

아시아경제Original source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Zhejiang Huakang Pharmaceutical Co., Ltd. Class A – SSE:605077

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

07/22/2026 - BIOTECH IN THE BALANCE - A Conversation with author Jeremy M. Levin, M.D.

KSFROriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene sinks in Korea after US phase 3 arthritis drug misses goals - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Aug. 11: ‘From Bench to Boardroom: Women Driving Innovation Across Biotech’

The University of Maryland, BaltimoreOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Is Collegium Pharmaceutical Inc (COLL) a Bargain After 3.1% Drop? GF Value Says Undervalued

GuruFocusOriginal source

🇺🇸Jul 23Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source

🇺🇸Jul 23Regulatorysec.govTier 1 · Regulatory source

Johnson & Johnson filed Form 10-Q

SEC EDGAROriginal source

🇺🇰Jul 23Regulatorynice.org.ukTier 1 · Regulatory source

The device that raised the alarm and saved my life

NICEOriginal source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

15 July 2026Traditional herbal remedies - quality and safety mattersProduct typeTraditional medicinesConsumer Safety Articles

Traditional herbal remedies - quality and safety matters This article has been migrated from an earl...

HSA (Singapore)Original source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

10 July 2026Recall of Remethan 100 R Tablet 100 mgAudiencesHealthcare professionalProduct typeTherapeutic ProductsRetail-level recall of one batch of Remethan 100 R Tablet 100 mg due to out-of-specification results in stability batchesProduct Recalls

Retail-level recall of one batch of Remethan 100 R Tablet 100 mg due to out-of-specification results...

HSA (Singapore)Original source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

14 July 2026Recall of Decondine SyrupAudiencesHealthcare professionalProduct typeTherapeutic ProductsRetail-level recall of all batches of Decondine Syrup, containing pseudoephedrine and triprolidine, within expiry due to out-of-specification results for triprolidine assay, pH and viscosityProduct Recalls

Retail-level recall of all batches of Decondine Syrup, containing pseudoephedrine and triprolidine,...

HSA (Singapore)Original source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

17 July 2026Recall of BD ChloraPrep™ 1 mL Applicator – Clear (17 July 2026)AudiencesHealthcare professionalProduct typeTherapeutic ProductsRetail-level recall of seven batches of BD ChloraPrep™ 1 mL Applicator – Clear due to potential breach of sterility in the packaging.Product Recalls

Retail-level recall of seven batches of BD ChloraPrep™ 1 mL Applicator – Clear due to potential brea...

HSA (Singapore)Original source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

15 July 2026How health supplements are regulated by HSAProduct typeHealth supplementsConsumer Safety Articles

How health supplements are regulated by HSA This article has been migrated from an earlier version o...

HSA (Singapore)Original source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

15 July 2026Getting savvy with health supplementsProduct typeHealth supplementsConsumer Safety Articles

This article has been migrated from an earlier version of the site and may display formatting incons...

HSA (Singapore)Original source

🇸🇬Jul 23Regulatoryhsa.gov.sgTier 1 · Regulatory source

23 July 20263 Consumers, Including a 12-Year-Old, Experienced Serious Adverse Effects After Taking Products with Banned or Potent Medicinal IngredientsAudiencesConsumerHealthcare professionalIndustry memberProduct typeChinese Proprietary MedicinesHealth supplementsPress Releases

HSA (Singapore)Original source

🇨🇭Jul 23Industrygalderma.comTier 1 · Company source

7 . 23 . 2026Press releaseGalderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency, raises net sales guidance for the full year

Ad hoc announcement pursuant to Art. 53 LR Zug, Switzerland, July 23, 2026 – Galderma Group AG (SIX:...

GaldermaOriginal source